Haryana became the first state in the country to issue Drug Manufacturing Licenses online: HM

Chandigarh : Haryana Health and Family Welfare Minister, Sh. Anil Vij said that Haryana has become the first state across the cournty, where online license will be issued to units of manufacturing of medicines.

Giving information in this regard, he said that the process of applying for license online is very simple. The applicant has to apply for his drug sales and manufacture/production license at statedrugs.gov.in portal. Apart from Haryana, three other states are Goa, Delhi and Jammu and Kashmir to issue online licenses for drug sales, while Haryana is the first state to issue online licenses for drug manufacturing, blood centers, etc.

Sh. Vij said that ONDLS portal was launched by him in Ambala recently. This has been possible due to the continuous efforts of Haryana Food and Drug Administration Department and Central Standard Control Organisation, Government of India.
He said that soon in addition to manufacturing license, necessary certificates for export and tender, such as sale certificate, non-conviction certificate, manufacturing and market standing certificate, pharmaceutical product certificate etc. will be applied online. This online process will save paper and time for preparation of huge files and corruption will also be curbed.

Calling upon the drug manufacturers, Sh. Vij said that the drug manufacturers set up its manufacturing units in Haryana and promote this process by applying online.

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad